There    are    several    words    to    describe    Dr.    Christopher    Boone:    health    futurist,    social    entrepreneur,    executive,    professor,    patient    advocate,    and    self-proclaimed    “data    hippie.”    Boone    is    recognized    as    being    a    dynamic,   ...

With nearly 30 years of experience in the biotech/pharmaceutical and medical device industries, Jim Caggiano is committed to advancing therapeutic options that improve the lives of patients. Having spent his career focused on areas of medicine where few or no effective options exist, including...

Scott is Director of the Antibody Therapeutics group at GNF. His group is responsible for a broad range of platform activities associated with early to late stage antibody drug discovery. Prior to joining GNF, Scott was Sr. Director and Site Head for Pfizer’s Centers for Therapeutic Innovation...

Brenda Hann is the Director of Clinical Research Operations in the Stanford Cancer Clinical Trials Office at Stanford Cancer Institute.  The Cancer Clinical Trials Office provides central coordination and oversight of clinical staff to ensure consistent processes, regulatory compliance and improved ...

Karin Jooss serves as Chief Scientific Officer of Gritstone Oncology.  Dr. Jooss joined Gritstone from Pfizer, where she served as head of Cancer Immunotherapeutics within the Vaccine Immunotherapeutics department for seven years.  While at Pfizer, she built and led immuno-oncology teams, was a...

Dr. Andrew Korytko is currently group leader in protein engineering at Eli Lilly and Company. He has been with Eli Lilly since 2004 and previously was at Applied Molecular Evolution for a number of years before it became a part of Eli Lilly in 2004. Dr. Korytko has over 25 years of experience in...

Johanna Mercier is President and Head of U.S. & France, Germany, Japan/Korea/Taiwan at Bristol-Myers Squibb, where she oversees a complex organization responsible for $17B in revenue annually, 80% of total company revenues.  In this leadership role, Johanna strives to instill a balance of...

Andrea has a BS in Finance, received her MD from  Georgetown Medical School and completed her radiology residency at the University of Pittsburgh. Prior to Merck, she was at GE Health Care, BioClinica, and a biotech company in Silicon Valley. Andrea has been at Merck for 6 years. She and her team...

Fred Ramsdell, PhD, is a veteran biotechnology leader in immunology with nearly three decades of experience. He currently leads the development of collaborative research programs at the Parker Institute for Cancer Immunotherapy as vice president of research.After a fellowship at the National...

Gary Starling is in the Protein Science Department at Merck Research Laboratories, based in the San Francisco Bay Area.  His career has focused on the Discovery and Early Development of Biologic therapeutics.  He began his career in the BioPharmaceutical industry at Bristol-Myers Squibb PRI working ...

Rhonda Pisk is dedicated clinical trial leader. She has been in Clinical Trials for over 15 years in multiple roles focusing on regulatory affairs, clinical trial operations and special issues in pediatric populations. Rhonda has a Bachelor’s degree in Microbiology and a Master’s degree in Health...

Mark Cobbold research focus relates to cancer antigenicity and modulating cancer antigen expression to correct the mismatch between antigenic display and TCR repertoire.  One approach has been to deliver immunodominant viral peptides to tumor cells using antibodies as delivery agents.  Another...

Sheila Frame, Vice President & Head Sandoz Biopharmaceuticals, North America, is responsible for the development and commercialization of the biosimilar medicines portfolio in the US and Canada. Sheila has more than 20 years of pharmaceutical experience and serves as a member of the Sandoz US...